Suppr超能文献

[血管紧张素转换酶抑制剂治疗心绞痛]

[Angiotensin-converting enzyme inhibitors in angina pectoris].

作者信息

Bussmann W D, Goerke S, Schneider W, Kaltenbach M

机构信息

Abteilung für Kardiologie, Klinikum der Universität Frankfurt/Main.

出版信息

Dtsch Med Wochenschr. 1988 Apr 8;113(14):548-50. doi: 10.1055/s-2008-1067680.

Abstract

In ten patients with angiographically demonstrated coronary heart disease exercise electrocardiograms were recorded before as well as two and four hours after administration of 5 or 10 mg Quinapril, an angiotensin converting enzyme inhibitor (ACEI). This reduced the sum of ST-segment depressions from 16.3 to 11.6 mV (P less than 0.001). While the heart rate remained unchanged, blood pressure fell from 147/91 to 119/79 mm Hg and the angina-free exercise time was clearly prolonged. Altogether there was a reduction of the ischaemia reaction by 35%. This perhaps speaks for an anti-anginal effect of ACEI, which could be of importance in the management of both hypertension and heart failure. In addition, the ACE inhibitors might be used as anti-angina drugs.

摘要

对10例经血管造影证实患有冠心病的患者,在服用5或10毫克喹那普利(一种血管紧张素转换酶抑制剂,ACEI)之前以及服用后两小时和四小时记录运动心电图。这使ST段压低总和从16.3毫伏降至11.6毫伏(P小于0.001)。心率保持不变的同时,血压从147/91毫米汞柱降至119/79毫米汞柱,且无心绞痛的运动时间明显延长。总的来说,缺血反应降低了35%。这或许表明ACEI具有抗心绞痛作用,这在高血压和心力衰竭的治疗中可能具有重要意义。此外,ACE抑制剂可用作抗心绞痛药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验